Can nebulised heparin reduce acute lung injury in patients with SARS‑CoV‑2 requiring advanced respiratory support in Ireland: the CHARTER‑Ireland phase Ib/IIa, randomised, parallel-group, open-label study.
Saved in:
| Title: | Can nebulised heparin reduce acute lung injury in patients with SARS‑CoV‑2 requiring advanced respiratory support in Ireland: the CHARTER‑Ireland phase Ib/IIa, randomised, parallel-group, open-label study. |
|---|---|
| Authors: | Cosgrave, David1,2 (AUTHOR), McNicholas, Bairbre1,2 (AUTHOR), Hanley, Ciara1,2 (AUTHOR), Sheehan, John Robert1 (AUTHOR), Calpin, Padraig1 (AUTHOR), Kernan, Maeve2 (AUTHOR), Murphy, Darragh2 (AUTHOR), Alvarez‑Iglesias, Alberto3 (AUTHOR), Ferguson, John3,4 (AUTHOR), Giacomini, Camilla1 (AUTHOR), Greene, Christine5 (AUTHOR), Cody, Catriona5 (AUTHOR), McGeary, Shane5 (AUTHOR), Murphy, Marion1 (AUTHOR), Fitzgerald, Marianne6 (AUTHOR), Curley, Gerard7 (AUTHOR), Dixon, Barry8 (AUTHOR), Smith, Roger J.8 (AUTHOR), Masterson, Claire2 (AUTHOR), O'Toole, Daniel2 (AUTHOR) |
| Source: | Intensive Care Medicine Experimental. 2/7/2025, Vol. 13 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2197425X |
|---|---|
| DOI: | 10.1186/s40635-025-00727-x |
